IHH Healthcare Berhad | Annual Report 2024 66 Governance Work Experience Mr Ashok Pandit, appointed as Group Chief Corporate Officer of IHH on 1 April 2024, is responsible for reshaping IHH’s portfolio to preserve, capitalise and create value-added opportunities in existing and new markets. He oversees corporate functions such as innovation, group strategy, business development, investments, performance management, sustainability, group communications, branding and IHH Laboratories, the laboratory network of IHH Healthcare, to ensure the organisation’s continued success in an ever-evolving healthcare landscape. Mr Pandit joined IHH in May 2021 as Group Chief Special Projects Officer, with over 28 years of investment banking experience in Asia Pacific. In August 2021, he took on an enlarged portfolio as Group Chief Strategy and Business Development Officer overseeing special projects, business strategy and business development. Before joining IHH, he was Managing Director, Global Co-Head of Sovereign Wealth and Pension Funds and Head of Financial Sponsor Coverage (Asia Pacific) at Deutsche Bank AG, Singapore. During his 15-year tenure at Deutsche Bank, Mr Pandit held senior investment banking positions, advising leading global institutions and corporations on capital raising, mergers and acquisitions, and advisory and capital restructuring. He led deals that raised over US$100 billion in the capital markets and was a key player in IHH’s US$2 billion IPO in 2012, which was ranked the world’s third largest IPO of the year. Academic/Professional Qualification(s) • Post Graduate Diploma in Management, Indian Institute of Management, Bangalore, India • Bachelor of Engineering (Mechanical), Delhi College of Engineering, India Ashok Pandit Group Chief Corporate Officer Nationality: Indian Gender: Male Age: 59 (As at 1 April 2025) Date of Appointment: 1 August 2021 Notes • Does not have any family relationships with any directors and/or any major shareholders of the Company • Does not have any conflict of interest with the Company • Does not have any convictions for offences within the past five years other than for traffic offences, if any Work Experience As Group Chief Medical Officer at IHH Healthcare, Adjunct Associate Professor (Adj Assoc. Prof) Keith Lim oversees clinical quality, patient safety, and value-based care across the group, setting policies and driving quality improvements, to ensure patients receive world-class and cost-effective care. With over 20 years of experience as a radiation oncologist, Adj Assoc. Prof Lim has made significant academic contributions, previously serving as Assistant Dean at the NUS School of Medicine. His research has been cited over 2000 times, and he has secured over S$2.5 million in research funding. Prior to IHH, he was Group Chief Value Officer at NUHS, pioneering Singapore’s value-based healthcare programme and leading efforts to optimise clinical and financial outcomes. He also served as Director of Clinical Outcomes and Value at Singapore’s Ministry of Health, where he set clinical standards and implemented value-driven care across public hospitals. His contributions have earned him Singapore’s National Medical Excellence Award, the highest medical honour in the country. Academic/Professional Qualification(s) • Bachelor of Medicine and Bachelor of Surgery (MBBS), National University of Singapore • Fellow of the Royal Australian and New Zealand College of Radiologists Adjunct Associate Professor Keith Lim Hsiu Chin Group Chief Medical Officer Nationality: Singaporean Gender: Male Age: 51 (As at 1 April 2025) Date of Appointment: 29 September 2021 Group Management
RkJQdWJsaXNoZXIy NDgzMzc=